Bischofsheim, Germany

Michael Weichel

USPTO Granted Patents = 7 

 

 

Average Co-Inventor Count = 10.0

ph-index = 3

Forward Citations = 21(Granted Patents)


Company Filing History:


Years Active: 2015-2025

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Michael Weichel: A Pioneering Innovator in Antibody Technology

Introduction

Michael Weichel, an accomplished inventor based in Bischofsheim, Germany, has made significant contributions to the field of antibody technology. With a prolific portfolio of six patents, Weichel has demonstrated a remarkable ability to innovate and push the boundaries of medical science.

Latest Patents

Among his latest inventions, Weichel's work on multivalent FV antibodies stands out. This patent focuses on a trispecific antibody molecule that incorporates a diabody-unit into a polypeptide chain containing at least six variable domains arranged sequentially. Notably, this design allows for two single-chain Fv (scFv) fragments to connect distally to the diabody-unit, thereby creating two additional antigen binding sites. Furthermore, his tandem diabody invention aims to enhance CD16A-directed NK-cell engagement by developing a multispecific antigen-binding molecule. This molecule is specifically designed to bind to CD16A and features two polypeptide chains, each containing at least four variable domains arranged in a specific order.

Career Highlights

Weichel has had a notable career, working with prominent companies in the biopharmaceutical industry. His tenure at Amphivena Therapeutics, Inc. and Affimed GmbH has allowed him to collaborate on groundbreaking projects in antibody engineering and cancer therapy.

Collaborations

Throughout his career, Weichel has collaborated with talented professionals, including coworkers Kristina Ellwanger and Ivica Fucek. These partnerships have facilitated the exchange of ideas and furthered advancements in their respective fields.

Conclusion

Michael Weichel's innovative work in developing advanced antibody technologies reflects his commitment to improving therapeutic options in medicine. His six patents serve as a testament to his creativity and expertise, marking him as a significant contributor to the ongoing evolution of biomedical sciences. As the landscape of antibody therapies continues to evolve, Weichel's contributions will undoubtedly pave the way for future breakthroughs.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…